Tailored Versus Coventional AntiPlaTelet Strategy Intended After OPTIMIZEd Drug Eluting Stent

Clinical trial NCT05418556 · RECRUITING

Trial details

NCT number: NCT05418556
Sponsor: Asan Medical Center
Status: RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Coronary Artery Disease

Start date: 2022-10-21
Primary completion: 2027-12-31
Enrollment: 3944

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.